Ge Healthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty approved drugs.
There are four US patents protecting GE HEALTHCARE drugs.
There are eighty patent family members on GE HEALTHCARE drugs in twenty-six countries and one hundred and thirty-seven supplementary protection certificates in eighteen countries.
Summary for Ge Healthcare
| International Patents: | 80 |
| US Patents: | 4 |
| Tradenames: | 58 |
| Ingredients: | 39 |
| NDAs: | 50 |
| Drug Master File Entries: | 5 |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | NEOSCAN | gallium citrate ga-67 | INJECTABLE;INJECTION | 017655-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-002 | Oct 25, 2013 | RX | Yes | Yes | 8,916,131 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ge Healthcare | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 017630-003 | Jan 8, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-002 | Sep 5, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 140 | iohexol | INJECTABLE;INJECTION | 018956-005 | Nov 30, 1988 | 4,396,597 | ⤷ Try a Trial |
| Ge Healthcare | INDIUM IN 111 OXYQUINOLINE | indium in-111 oxyquinoline | INJECTABLE;INJECTION | 019044-001 | Dec 24, 1985 | 4,335,095 | ⤷ Try a Trial |
| Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | 4,278,654 | ⤷ Try a Trial |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | 4,278,654 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Belgium | 2015C005 | ⤷ Try a Trial |
| European Patent Office | 2264018 | ⤷ Try a Trial |
| Norway | 20110980 | ⤷ Try a Trial |
| Spain | 2536449 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2957286 | 2018C/047 | Belgium | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| 0521471 | SPC/GB03/033 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321 |
| 2957286 | 6/2019 | Austria | ⤷ Try a Trial | PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721 |
| 1853250 | 238 50005-2014 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: PAKLITAXEL VO FORME NANOCASTIC VIAZANYCH NA ALBUMIN; REGISTRATION NO/DATE: EU/1/07/428/001 - EU/1/07/428/002 20131230 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
